Notice: This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends DEH vs. ENOV, CDRE, ESTA, AVNS, SMTI, INGN, LAKE, ZJYL, RBOT, and MLSSShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Enovis (ENOV), Cadre (CDRE), Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Vicarious Surgical (RBOT), and Milestone Scientific (MLSS). D8 vs. Enovis Cadre Establishment Labs Avanos Medical Sanara MedTech Inogen Lakeland Industries Jin Medical International Vicarious Surgical Milestone Scientific Enovis (NYSE:ENOV) and D8 (NYSE:DEH) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk. Is ENOV or DEH more profitable? D8 has a net margin of 0.00% compared to Enovis' net margin of -5.95%. Enovis' return on equity of 4.39% beat D8's return on equity.Company Net Margins Return on Equity Return on Assets Enovis-5.95% 4.39% 2.80% D8 N/A N/A N/A Do analysts prefer ENOV or DEH? Enovis currently has a consensus price target of $67.00, indicating a potential upside of 55.38%. Given Enovis' stronger consensus rating and higher probable upside, equities research analysts clearly believe Enovis is more favorable than D8.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enovis 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89D8 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in ENOV or DEH? 98.4% of Enovis shares are held by institutional investors. Comparatively, 65.4% of D8 shares are held by institutional investors. 2.4% of Enovis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, ENOV or DEH? D8 has lower revenue, but higher earnings than Enovis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnovis$2.00B1.20-$33.26M-$2.19-19.69D8N/AN/A-$9.46MN/AN/A Does the media prefer ENOV or DEH? In the previous week, Enovis had 4 more articles in the media than D8. MarketBeat recorded 4 mentions for Enovis and 0 mentions for D8. Enovis' average media sentiment score of 1.14 beat D8's score of -0.73 indicating that Enovis is being referred to more favorably in the media. Company Overall Sentiment Enovis Positive D8 Negative Does the MarketBeat Community favor ENOV or DEH? Enovis received 29 more outperform votes than D8 when rated by MarketBeat users. CompanyUnderperformOutperformEnovisOutperform Votes2961.70% Underperform Votes1838.30% D8N/AN/A SummaryEnovis beats D8 on 11 of the 13 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$517.50M$9.52B$5.14B$19.18BDividend YieldN/A1.39%5.09%3.63%P/E RatioN/A19.5690.0541.24Price / SalesN/A32.801,116.2517.51Price / CashN/A22.3743.1021.28Price / Book100.005.494.785.32Net Income-$9.46M$182.72M$120.31M$989.88M D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$12.00-0.2%N/A+2,709.6%$517.50MN/A0.003ENOVEnovis2.9757 of 5 stars$47.43-0.4%$67.00+41.3%-23.8%$2.65B$1.71B0.006,550Positive NewsCDRECadre3.0762 of 5 stars$35.28-0.7%$39.75+12.7%+6.2%$1.43B$482.53M42.512,435ESTAEstablishment Labs2.5174 of 5 stars$43.27-1.5%$60.60+40.1%+65.7%$1.21B$165.15M0.00960Positive NewsAVNSAvanos Medical3.4859 of 5 stars$18.54+0.4%N/A-30.1%$852.10M$673.30M54.323,771SMTISanara MedTech1.9962 of 5 stars$35.98-1.8%$44.00+22.3%-13.9%$314.50M$78.06M-36.3460High Trading VolumeINGNInogen2.5623 of 5 stars$9.51+0.1%$7.00-26.4%+43.5%$226.53M$315.66M0.00834Analyst DowngradeNews CoverageLAKELakeland Industries4.5789 of 5 stars$22.04-4.0%$26.50+20.2%+26.0%$163.10M$124.69M0.001,750Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeZJYLJin Medical InternationalN/A$0.80+11.1%N/A-98.8%$123.69M$19.82M0.00245Positive NewsGap UpRBOTVicarious Surgical1.2841 of 5 stars$15.11-6.1%$10.25-32.2%+3.5%$89.30MN/A-1.473Positive NewsHigh Trading VolumeMLSSMilestone Scientific2.1552 of 5 stars$0.90+2.0%$1.25+38.4%+57.4%$70.33M$9.83M0.0030Analyst ForecastNews Coverage Related Companies and Tools Related Companies ENOV Competitors CDRE Competitors ESTA Competitors AVNS Competitors SMTI Competitors INGN Competitors LAKE Competitors ZJYL Competitors RBOT Competitors MLSS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:DEH) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
